Cargando…

Respiratory Virus Vaccines

This chapter reviews the main viral pathogens of the respiratory tract, the immune responses they induce, currently available vaccines, and vaccines that are in development to control them. The main viruses responsible for acute respiratory infection in people include respiratory syncytial, influenz...

Descripción completa

Detalles Bibliográficos
Autores principales: Broadbent, Andrew J., Boonnak, Kobporn, Subbarao, Kanta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149605/
http://dx.doi.org/10.1016/B978-0-12-415847-4.00059-8
_version_ 1783520841746612224
author Broadbent, Andrew J.
Boonnak, Kobporn
Subbarao, Kanta
author_facet Broadbent, Andrew J.
Boonnak, Kobporn
Subbarao, Kanta
author_sort Broadbent, Andrew J.
collection PubMed
description This chapter reviews the main viral pathogens of the respiratory tract, the immune responses they induce, currently available vaccines, and vaccines that are in development to control them. The main viruses responsible for acute respiratory infection in people include respiratory syncytial, influenza, human parainfluenza, human metapneumo-, human rhino-, corona-, and adenoviruses. Licensed vaccines are available only for influenza virus, with vaccines against the other pathogens either in clinical trials or in preclinical stages of development. The majority of studies evaluating respiratory virus vaccines measure serum antibody responses, because, although both cellular and humoral responses contribute to the clearance of a primary infection, neutralizing antibodies are known to protect against secondary infection. Humoral responses can be readily detected after vaccination with inactivated or subunit vaccines; however, fewer individuals seroconvert after vaccination with live vaccines. Alternative immune mechanisms such as mucosal antibody responses are probably responsible for protection by live attenuated vaccines, and immune correlates of protection are under investigation.
format Online
Article
Text
id pubmed-7149605
institution National Center for Biotechnology Information
language English
publishDate 2015
record_format MEDLINE/PubMed
spelling pubmed-71496052020-04-13 Respiratory Virus Vaccines Broadbent, Andrew J. Boonnak, Kobporn Subbarao, Kanta Mucosal Immunology Article This chapter reviews the main viral pathogens of the respiratory tract, the immune responses they induce, currently available vaccines, and vaccines that are in development to control them. The main viruses responsible for acute respiratory infection in people include respiratory syncytial, influenza, human parainfluenza, human metapneumo-, human rhino-, corona-, and adenoviruses. Licensed vaccines are available only for influenza virus, with vaccines against the other pathogens either in clinical trials or in preclinical stages of development. The majority of studies evaluating respiratory virus vaccines measure serum antibody responses, because, although both cellular and humoral responses contribute to the clearance of a primary infection, neutralizing antibodies are known to protect against secondary infection. Humoral responses can be readily detected after vaccination with inactivated or subunit vaccines; however, fewer individuals seroconvert after vaccination with live vaccines. Alternative immune mechanisms such as mucosal antibody responses are probably responsible for protection by live attenuated vaccines, and immune correlates of protection are under investigation. 2015 2015-03-13 /pmc/articles/PMC7149605/ http://dx.doi.org/10.1016/B978-0-12-415847-4.00059-8 Text en Copyright © 2015 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Broadbent, Andrew J.
Boonnak, Kobporn
Subbarao, Kanta
Respiratory Virus Vaccines
title Respiratory Virus Vaccines
title_full Respiratory Virus Vaccines
title_fullStr Respiratory Virus Vaccines
title_full_unstemmed Respiratory Virus Vaccines
title_short Respiratory Virus Vaccines
title_sort respiratory virus vaccines
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149605/
http://dx.doi.org/10.1016/B978-0-12-415847-4.00059-8
work_keys_str_mv AT broadbentandrewj respiratoryvirusvaccines
AT boonnakkobporn respiratoryvirusvaccines
AT subbaraokanta respiratoryvirusvaccines